Amin Nassar, M.D., is a hematology/oncology fellow at Yale University. He received his medical degree from the American University of Beirut and completed residency at Brigham and Women’s Hospital. Dr. Nassar also pursued a two-year postdoctoral training at Brigham and Women’s Hospital where he worked under the mentorship of Professors Dr. David Kwiatkowski, Dr. Toni Choueiri, and Dr. Matthew Freedman at Harvard Medical School. His research focuses on the identification of genomic biomarkers across ancestral populations with cancer. Dr. Nassar currently serves on the editorial board of “Molecular biology reports”, “Translational oncology”, and “Frontiers in Oncology”. He is also one of the Associate Guest editors for the journal “Frontiers in Oncology”. He has published >50 original articles, 20 as first or co-first author, which include, as detailed below, first-author papers in Nature Communications, Cancer Cell, Journal of Clinical Oncology, Journal of Thoracic Oncology, JNCI, and The New England Journal of Medicine. He has also been an invited speaker to several conferences including AACR, XXIV SBOC, Korean Society of Medical Oncology, and Prostate Cancer Foundation. Dr. Nassar is interested in a career as a physician-scientist with a clinical focus in thoracic oncology. He is currently pursuing a PhD in tumor immunology at the Flavell lab.